Insider Transactions in Q1 2025 at Rocket Pharmaceuticals, Inc. (RCKT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2025
|
Jonathan David Schwartz |
SELL
Open market or private sale
|
Direct |
6,532
-2.68%
|
$65,320
$10.58 P/Share
|
|
Feb 21
2025
|
Gaurav Shah CEO |
SELL
Open market or private sale
|
Direct |
16,303
-2.07%
|
$163,030
$10.58 P/Share
|
|
Feb 21
2025
|
John Militello |
SELL
Open market or private sale
|
Direct |
2,737
-4.0%
|
$27,370
$10.58 P/Share
|
|
Feb 21
2025
|
Martin Wilson General Counsel |
SELL
Open market or private sale
|
Direct |
3,222
-2.09%
|
$32,220
$10.58 P/Share
|
|
Feb 21
2025
|
Kinnari Patel |
SELL
Open market or private sale
|
Direct |
6,078
-1.35%
|
$60,780
$10.58 P/Share
|
|
Feb 11
2025
|
John Militello |
BUY
Grant, award, or other acquisition
|
Direct |
20,080
+22.67%
|
-
|
|
Feb 11
2025
|
Aaron Ondrey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,358
+39.72%
|
-
|
|
Feb 11
2025
|
Kinnari Patel |
BUY
Grant, award, or other acquisition
|
Direct |
57,786
+11.38%
|
-
|
|
Feb 11
2025
|
Jonathan David Schwartz |
BUY
Grant, award, or other acquisition
|
Direct |
80,318
+24.12%
|
-
|
|
Feb 11
2025
|
Gaurav Shah CEO |
BUY
Grant, award, or other acquisition
|
Direct |
81,655
+9.38%
|
-
|
|
Feb 11
2025
|
Martin Wilson General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
90,358
+36.99%
|
-
|
|
Jan 23
2025
|
John Militello |
SELL
Open market or private sale
|
Direct |
896
-1.82%
|
$8,960
$10.38 P/Share
|